Claire Elizabeth Powers Smith MD
Assistant Professor, Hematology & Medical Oncology
820 Harrison Ave | (617) 638-7011cepsmith@bu.edu
Sections
Hematology & Medical Oncology
Biography
Dr. Claire Smith, MD received her undergraduate degree from the University of Washington and her medical degree from Duke University, where she also completed her residency. While at Duke, she was the recipient of several research awards and scholarships, and recently published a study examining national trends in end of life care at the Veterans Health Administration.
Education
MD, Duke University School of Medicine
Anthropology, BA, University of Washington
Publications
Barmettler G, Leonard S, Giannakou A, Park KU, Smith CE, Mittendorf EA, King TA, Kantor O. ASO Visual Abstract: Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities. Ann Surg Oncol. 2026 Apr; 33(4):3405-3406. PMID: 41572120.
Published on 12/11/2025Barmettler G, Leonard S, Giannakou A, Park KU, Smith CE, Mittendorf EA, King TA, Kantor O. Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities. Ann Surg Oncol. 2026 Apr; 33(4):3302-3310. PMID: 41381928.
Published on 6/2/2023Olivier T, Smith CEP, Haslam A, Addeo A, Prasad V. Quality of life in the adjuvant setting: A meta-analysis of US Food and Drug Administration approved anti-cancer drugs from 2018 to 2022. J Cancer Policy. 2023 Sep; 37:100426. PMID: 37270063.
Published on 9/10/2022Smith CEP, Marcom PK, Mitri Z, Ko NY. Predictors of long-term durable response in de novo HER2-positive metastatic breast cancer and the real-world treatment experience at two institutions. Breast Cancer Res Treat. 2022 Nov; 196(1):215-220. PMID: 36087190.
Published on 6/2/2022Abd El-Salam MA, Smith CEP, Pan CX. Insights on recent innovations in bladder cancer immunotherapy. Cancer Cytopathol. 2022 Sep; 130(9):667-683. PMID: 35653623.
Published on 5/3/2021Smith CEP, Prasad V. Assessment of New Molecular Entities Approved for Cancer Treatment in 2020. JAMA Netw Open. 2021 05 03; 4(5):e2112558. PMID: 34047795.
Published on 2/18/2021West MT, Smith CE, Kaempf A, Kohs TCL, Amirsoltani R, Ribkoff J, Choung JL, Palumbo A, Mitri Z, Shatzel JJ. CDK 4/6 inhibitors are associated with a high incidence of thrombotic events in women with breast cancer in real-world practice. Eur J Haematol. 2021 May; 106(5):634-642. PMID: 33527479.
Published on 2/4/2021Smith JS, Said JT, Elman SA, Smith CEP, Merola JF. Seroconversion of severe acute respiratory syndrome coronavirus 2-infected patients on immunosuppression: A retrospective analysis. J Am Acad Dermatol. 2021 May; 84(5):1409-1412. PMID: 33549649.
Published on 2/1/2021Smith CEP, Prasad V. Targeted Cancer Therapies. Am Fam Physician. 2021 02 01; 103(3):155-163. PMID: 33507053.
Published on 5/2/2019Smith CEP, Kamal AH, Kluger M, Coke P, Kelley MJ. National Trends in End-of-Life Care for Veterans With Advanced Cancer in the Veterans Health Administration: 2009 to 2016. J Oncol Pract. 2019 Jun; 15(6):e568-e575. PMID: 31046573.